Analytical and physiological characteristics of prostate-specific antigen and prostatic acid phosphatase in serum compared.

Ronald B Schifman, Frederick R Ahmann, A. Elvick, M. Ahmann, K. Coulis, M. K. Brawer

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

We did a comparative analysis of the physiological and analytical properties of prostate-specific antigen (PSA), acid phosphatase (ACP; EC 3.1.32) activity, and acid phosphatase antigen (PAP) in serum. The PSA assay is sensitive to 0.2 microgram/L and demonstrates good linearity (y = 1.01x + 0.74). The CV was 3.9% at 40 micrograms/L, 8.0% at 3.1 micrograms/L. PSA and PAP are less stable at 4 degrees C than at -20 degrees C. Serum PAP and ACP concentrations showed large intra-individual fluctuations (average CVs of 22% and 24%, respectively), which were not observed with PSA measurements (average CV 6.2%). We saw significant correlation with the magnitude of physiological change when analytes were compared for serially collected split samples [y(PSA) = 0.14x(PAP) + 0.00, r = 0.767], which indicates that a common factor is influencing this variation. The excellent analytical performance, tissue specificity, and small degree of intra-individual variance are characteristics that favor the measurement of PSA in serum for monitoring patients with prostatic cancer.

Original languageEnglish (US)
Pages (from-to)2086-2088
Number of pages3
JournalClinical Chemistry
Volume33
Issue number11
StatePublished - Nov 1987
Externally publishedYes

Fingerprint

Prostate-Specific Antigen
Serum
Acid Phosphatase
Patient monitoring
Organ Specificity
Physiologic Monitoring
prostatic acid phosphatase
Assays
Prostatic Neoplasms
Tissue
Antigens

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Analytical and physiological characteristics of prostate-specific antigen and prostatic acid phosphatase in serum compared. / Schifman, Ronald B; Ahmann, Frederick R; Elvick, A.; Ahmann, M.; Coulis, K.; Brawer, M. K.

In: Clinical Chemistry, Vol. 33, No. 11, 11.1987, p. 2086-2088.

Research output: Contribution to journalArticle

@article{1e2053a2442e42e2a567a4d0d9fd77f3,
title = "Analytical and physiological characteristics of prostate-specific antigen and prostatic acid phosphatase in serum compared.",
abstract = "We did a comparative analysis of the physiological and analytical properties of prostate-specific antigen (PSA), acid phosphatase (ACP; EC 3.1.32) activity, and acid phosphatase antigen (PAP) in serum. The PSA assay is sensitive to 0.2 microgram/L and demonstrates good linearity (y = 1.01x + 0.74). The CV was 3.9{\%} at 40 micrograms/L, 8.0{\%} at 3.1 micrograms/L. PSA and PAP are less stable at 4 degrees C than at -20 degrees C. Serum PAP and ACP concentrations showed large intra-individual fluctuations (average CVs of 22{\%} and 24{\%}, respectively), which were not observed with PSA measurements (average CV 6.2{\%}). We saw significant correlation with the magnitude of physiological change when analytes were compared for serially collected split samples [y(PSA) = 0.14x(PAP) + 0.00, r = 0.767], which indicates that a common factor is influencing this variation. The excellent analytical performance, tissue specificity, and small degree of intra-individual variance are characteristics that favor the measurement of PSA in serum for monitoring patients with prostatic cancer.",
author = "Schifman, {Ronald B} and Ahmann, {Frederick R} and A. Elvick and M. Ahmann and K. Coulis and Brawer, {M. K.}",
year = "1987",
month = "11",
language = "English (US)",
volume = "33",
pages = "2086--2088",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "11",

}

TY - JOUR

T1 - Analytical and physiological characteristics of prostate-specific antigen and prostatic acid phosphatase in serum compared.

AU - Schifman, Ronald B

AU - Ahmann, Frederick R

AU - Elvick, A.

AU - Ahmann, M.

AU - Coulis, K.

AU - Brawer, M. K.

PY - 1987/11

Y1 - 1987/11

N2 - We did a comparative analysis of the physiological and analytical properties of prostate-specific antigen (PSA), acid phosphatase (ACP; EC 3.1.32) activity, and acid phosphatase antigen (PAP) in serum. The PSA assay is sensitive to 0.2 microgram/L and demonstrates good linearity (y = 1.01x + 0.74). The CV was 3.9% at 40 micrograms/L, 8.0% at 3.1 micrograms/L. PSA and PAP are less stable at 4 degrees C than at -20 degrees C. Serum PAP and ACP concentrations showed large intra-individual fluctuations (average CVs of 22% and 24%, respectively), which were not observed with PSA measurements (average CV 6.2%). We saw significant correlation with the magnitude of physiological change when analytes were compared for serially collected split samples [y(PSA) = 0.14x(PAP) + 0.00, r = 0.767], which indicates that a common factor is influencing this variation. The excellent analytical performance, tissue specificity, and small degree of intra-individual variance are characteristics that favor the measurement of PSA in serum for monitoring patients with prostatic cancer.

AB - We did a comparative analysis of the physiological and analytical properties of prostate-specific antigen (PSA), acid phosphatase (ACP; EC 3.1.32) activity, and acid phosphatase antigen (PAP) in serum. The PSA assay is sensitive to 0.2 microgram/L and demonstrates good linearity (y = 1.01x + 0.74). The CV was 3.9% at 40 micrograms/L, 8.0% at 3.1 micrograms/L. PSA and PAP are less stable at 4 degrees C than at -20 degrees C. Serum PAP and ACP concentrations showed large intra-individual fluctuations (average CVs of 22% and 24%, respectively), which were not observed with PSA measurements (average CV 6.2%). We saw significant correlation with the magnitude of physiological change when analytes were compared for serially collected split samples [y(PSA) = 0.14x(PAP) + 0.00, r = 0.767], which indicates that a common factor is influencing this variation. The excellent analytical performance, tissue specificity, and small degree of intra-individual variance are characteristics that favor the measurement of PSA in serum for monitoring patients with prostatic cancer.

UR - http://www.scopus.com/inward/record.url?scp=0023442660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023442660&partnerID=8YFLogxK

M3 - Article

VL - 33

SP - 2086

EP - 2088

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 11

ER -